Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Non-Current Assets (2016 - 2025)

Orthopediatrics has reported Non-Current Assets over the past 10 years, most recently at $202.7 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $202.7 million for Q4 2025, up 9.28% from a year ago — trailing twelve months through Dec 2025 was $202.7 million (up 9.28% YoY), and the annual figure for FY2025 was $202.7 million, up 9.28%.
  • Non-Current Assets for Q4 2025 was $202.7 million at Orthopediatrics, up from $196.4 million in the prior quarter.
  • Over the last five years, Non-Current Assets for KIDS hit a ceiling of $202.7 million in Q4 2025 and a floor of $133.0 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $170.2 million (2022), compared with a mean of $168.0 million.
  • Biggest five-year swings in Non-Current Assets: surged 279.95% in 2021 and later decreased 1.86% in 2023.
  • Orthopediatrics' Non-Current Assets stood at $142.1 million in 2021, then rose by 17.32% to $166.7 million in 2022, then grew by 2.69% to $171.2 million in 2023, then rose by 8.32% to $185.4 million in 2024, then rose by 9.28% to $202.7 million in 2025.
  • The last three reported values for Non-Current Assets were $202.7 million (Q4 2025), $196.4 million (Q3 2025), and $193.0 million (Q2 2025) per Business Quant data.